4925 — HABA LABORATORIES Income Statement

0.000.00%

Last trade - 00:00

Consumer DefensivesConservativeMicro CapContrarian

Annual income statement for HABA LABORATORIES, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.

	2021 March 31st	2022 March 31st	2023 March 31st	2024 March 31st	2025 March 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Yuho	Yuho	Yuho	Yuho	Yuho
Standards:	JAS	JAS	JAS	JAS	JAS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	14,308	12,909	12,038	12,324	12,062
Cost of Revenue
Gross Profit	10,200	8,795	8,169	8,404	8,093
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	14,073	13,202	12,623	14,160	11,453
Operating Profit	235	-293	-585	-1,836	609
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	284	-267	-549	-1,843	636
Provision for Income Taxes
Net Income After Taxes	216	-269	-708	-2,119	577
Net Income Before Extraordinary Items
Net Income	216	-269	-708	-2,119	577
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	216	-269	-708	-2,119	577
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	50.5	-75.5	-193	-276	148
Dividends per Share